Furthermore, previous study revealed a potential novel role for SHMT2 as a downstream element of the STAT3 signaling pathway, and this molecular mechanism may be responsible for the transition of prostate cancer towards a more aggressive phenotype [34]. This evidence concerns the gene STAT3 and prostate carcinoma.